Origin Biologics
Matt Heyerdahl currently serves as the Chief Financial Officer for both Origin Biologics and Donor Services Laboratory since August 2025. Prior to these roles, Matt held the position of Vice President of Accounting at P3 Health Partners from September 2022 to June 2025, focusing on financial analysis and process improvement. Earlier experience includes serving as Chief Financial Officer at Acres in 2022 and at Gaming Arts, LLC, where Matt was Chief Financial Officer from January 2021 to January 2022 and held the roles of Chief Accounting Officer and Director of Finance from February 2020 to January 2021. Matt earned dual BBA degrees in Accounting and Real Estate & Urban Land Economics from the Wisconsin School of Business in January 2008.
This person is not in any teams
This person is not in any offices